--- title: "Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday" type: "News" locale: "en" url: "https://longbridge.com/en/news/295533732.md" description: "Wall Street analysts updated outlooks on several stocks. Oppenheimer raised Target's price target to $170, maintaining an Outperform rating. Truist upgraded Best Buy to Buy with a $95 target. BTIG raised Spyre Therapeutics' target to $132. Needham increased Axsome Therapeutics' target slightly. Mizuho raised Marathon Petroleum's target to $304. Cantor Fitzgerald raised Apple Hospitality REIT's target to $18. Conversely, Keefe Bruyette downgraded Marketaxess and cut its target; B of A downgraded Applovin and cut its target; Barclays downgraded Gap and cut its target." datetime: "2026-08-11T11:59:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295533732.md) - [en](https://longbridge.com/en/news/295533732.md) - [zh-HK](https://longbridge.com/zh-HK/news/295533732.md) --- # Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. - Keefe, Bruyette & Woods raised the price target for **Marketaxess Holdings Inc** (NASDAQ:MKTX) from $150 to $167. Keefe, Bruyette & Woods analyst Chris Allen downgraded the stock from Outperform to Market Perform. Marketaxess shares closed at $162.50 on Monday. See how other analysts view this stock. - Truist Securities boosted **Best Buy Co Inc** (NYSE:BBY) price target from $81 to $95. Truist Securities analyst Scot Ciccarelli upgraded the stock from Hold to Buy. Best Buy shares closed at $82.43 on Monday. See how other analysts view this stock. - B of A Securities slashed price target for **Applovin Corp** (NASDAQ:APP) from $430 to $400. B of A Securities analyst Omar Dessouky downgraded the stock from Buy to Neutral. Applovin shares closed at $339.00 on Monday. See how other analysts view this stock. - BTIG raised the price target for **Spyre Therapeutics Inc** (NASDAQ:SYRE) from $112 to $132. BTIG analyst Julian Harrison maintained a Buy rating. Spyre Therapeutics shares closed at $105.33 on Monday. See how other analysts view this stock. - Needham increased **Axsome Therapeutics Inc** (NASDAQ:AXSM) price target from $267 to $268. Needham analyst Ami Fadia maintained a Buy rating. Axsome Therapeutics shares closed at $220.89 on Monday. See how other analysts view this stock. - Barclays cut **Gap Inc** (NYSE:GAP) price target from $26 to $20. Barclays analyst Adrienne Yih downgraded the stock from Overweight to Equal-Weight. Gap shares closed at $21.51 on Monday. See how other analysts view this stock. - Mizuho raised **Marathon Petroleum Corp** (NYSE:MPC) price target from $284 to $304. Mizuho analyst Nitin Kumar maintained a Neutral rating. Marathon Petroleum shares closed at $320.32 on Monday. See how other analysts view this stock. - Oppenheimer raised the price target for **Okta Inc** (NASDAQ:OKTA) from $125 to $170. Oppenheimer analyst Shaul Eyal maintained an Outperform rating. Okta shares closed at $150.77 on Monday. See how other analysts view this stock. - Cantor Fitzgerald raised **Apple Hospitality REIT Inc** (NYSE:APLE) price target from $16 to $18. Cantor Fitzgerald analyst Jay Kornreich maintained an Overweight rating. Apple Hospitality shares closed at $15.71 on Monday. See how other analysts view this stock. - Oppenheimer boosted **Target Corp** (NYSE:TGT) price target from $140 to $170. Oppenheimer analyst Rupesh Parikh maintained an Outperform rating. Target shares closed at $152.02 on Monday. See how other analysts view this stock. Considering buying TGT stock? Here’s what analysts think: _Photo via Shutterstock_ ### Related Stocks - [BBY.US](https://longbridge.com/en/quote/BBY.US.md) - [AXSM.US](https://longbridge.com/en/quote/AXSM.US.md) - [APLE.US](https://longbridge.com/en/quote/APLE.US.md) - [SYRE.US](https://longbridge.com/en/quote/SYRE.US.md) - [APP.US](https://longbridge.com/en/quote/APP.US.md) - [MPC.US](https://longbridge.com/en/quote/MPC.US.md) - [GAP.US](https://longbridge.com/en/quote/GAP.US.md) - [TGT.US](https://longbridge.com/en/quote/TGT.US.md) - [APPX.US](https://longbridge.com/en/quote/APPX.US.md) - [MKTX.US](https://longbridge.com/en/quote/MKTX.US.md) - [OKTA.US](https://longbridge.com/en/quote/OKTA.US.md) ## Related News & Research - [Analysts Are Slashing Price Targets on AppLovin Stock. Here's Why.](https://longbridge.com/en/news/295259264.md) - [AppLovin Analysts Cut Their Forecasts Following Q2 Earnings](https://longbridge.com/en/news/295101631.md) - [APLE: Q2 2026 saw strong RevPAR growth, higher earnings, and extended credit capacity](https://longbridge.com/en/news/295010207.md) - [Why AppLovin stock tumbled today](https://longbridge.com/en/news/295129489.md) - [Apple Hospitality REIT Q2 net income rises on expense management](https://longbridge.com/en/news/295015208.md)